Non-biotinylated Cynomolgus IL-17A/CTLA-8 Protein (ILA-CM417)
Non-biotinylated Cynomolgus IL-17A/CTLA-8 Protein (ILA-CM417)
Non-biotinylated Cynomolgus IL-17A/CTLA-8 Protein (ILA-CM417)
  • Express System: HEK293
  • Product Tag: C-His-Avi
  • Purity: > 95% as determined by Bis-Tris PAGE
  • Activity: Immobilized Cynomolgus IL-17A, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Human IL-17R alpha, hFc Tag with the EC50 of 0.10ug/ml determined by ELISA. See testing image for detail.
  • Amino Acid Range: Gly24-Ala155
Catalog #ILA-CM417
Regular price $346.50
/
Size

Order now, ships by:

Product Description

Recombinant Cynomolgus IL-17A/CTLA-8 Protein is expressed from HEK293 with His tag and Avi tag at the C-Terminus.It contains Gly24-Ala155.

Product Background

Interleukin‑17A (IL‑17A), also known as CTLA‑8, is a 15‑20 kDa glycosylated cytokine that plays an important role in anti‑microbial and chronic inflammation. The six IL‑17 cytokines (IL‑17A‑F) are encoded by separate genes but adopt a conserved cystine knot fold.IL-17A is a ligand for IL17RA and IL17RC. The heterodimer formed by IL17A and IL17F is a ligand for the heterodimeric complex formed by IL17RA and IL17RC. Involved in inducing stromal cells to produce proinflammatory and hematopoietic cytokines.

Product Category

Recombinant Protein / Antibody discovery / Antibody discovery | Others
Protein
IL-17A/CTLA-8
Synonyms
CTLA-8; IL17; IL17A; IL-17CTLA-8; interleukin 17A
Accession
Species
Cynomolgus
Biotinylated
no
Amino Acid Range
Gly24-Ala155
Molecular Weight
The protein has a predicted MW of 18.2 kDa. Due to glycosylation, the protein migrates to 26-32 kDa based on Bis-Tris PAGE result.
Activity
Immobilized Cynomolgus IL-17A, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Human IL-17R alpha, hFc Tag with the EC50 of 0.10ug/ml determined by ELISA. See testing image for detail.

Product Tag

C-His-Avi
Expression System
HEK293
Purity
> 95% as determined by Bis-Tris PAGE
Endotoxin
Less than 1 EU per ug by the LAL method.
Form
Lyophilized
Shipping
Shipped at ambient temperature.
Formulation
Lyophilized from 0.22um filtered solution in PBS (pH 7.4). Normally 8% trehalose is added as protectant before lyophilization.
Reconstitution
Dissolve the lyophilized protein in distilled water. It is recommended to resuspend at 0.5 mg/mL if the lyophilized powder is 100 ug or less, at 1mg/ml for 500ug or 1mg lyophilized powder. Do not mix by vortex or vigorous shaking.
Stability And Storage
-20 to -80°C for 24 months as supplied from date of receipt.;-80°C for 3 months after reconstitution.;Recommend to aliquot the protein into smaller quantities for optimal storage. Please minimize freeze-thaw cycles.
Immobilized Cynomolgus IL-17A, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Human IL-17R alpha, hFc Tag with the EC50 of 0.10ug/ml determined by ELISA. Immobilized Cynomolgus IL-17A, His Tag at 1ug/ml (100ul/well) on the plate. Dose response curve for Human IL-17R alpha, hFc Tag with the EC50 of 0.10ug/ml determined by ELISA.
Immobilized Cynomolgus IL-17A, His Tag at 2ug/ml (100ul/well) on the plate. Dose response curve for Anti-IL-17A Antibody, hFc Tag with the EC50 of 4.4ng/ml determined by ELISA. Immobilized Cynomolgus IL-17A, His Tag at 2ug/ml (100ul/well) on the plate. Dose response curve for Anti-IL-17A Antibody, hFc Tag with the EC50 of 4.4ng/ml determined by ELISA.
Cynomolgus IL-17A on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. Cynomolgus IL-17A on Bis-Tris PAGE under reduced condition. The purity is greater than 95%.
Have more questions?

Check out our Frequently Asked Questions page for more details about product specifications, ordering, and shipments.

Recently viewed